Revvity (RVTY) EBIT Margin (2009 - 2026)
Revvity's (RVTY) quarterly EBIT Margin came in at 12.24% in Q3 2026, down 36.0% on a YoY basis from 19.13% in Q3 2025, and up 14.7% quarter-over-quarter from 10.67% in Q2 2026.
Analysis
Revvity (RVTY) EBIT Margin (2009 - 2026) Analysis & Trends
Revvity (RVTY) has reported EBIT Margin for 18 consecutive years, with 12.24% the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, EBIT Margin fell 36.0% year-over-year to 12.24%; the trailing twelve-month figure through Jul 2026 stood at 12.32% (down 125.0% YoY), and the FY2025 full-year result was 12.49%, down 10.0% from the prior year.
- EBIT Margin improved to 12.24% in Q3 2026 per RVTY's latest filing, from 10.67% in the prior quarter.
- Across five years, EBIT Margin topped out at 29.18% in Q1 2022 and bottomed at 6.79% in Q1 2024.
- Historically, EBIT Margin has averaged 15.08% across 5 years, with a median of 12.5% in 2024.
- The sharpest annual moves came in 2022 and 2025: EBIT Margin tumbled 1707 bps in 2022, then soared 408 bps in 2025.
- Over 5 years, EBIT Margin stood at 15.56% in 2022, then sank by 34 bps to 10.32% in 2023, then surged by 58 bps to 16.28% in 2024, then declined by 11 bps to 14.47% in 2025, then declined by 15 bps to 12.24% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 12.24%, 10.67%, and 14.47% for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 17.99% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 23.64% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 21.14% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 12.24% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 23.13% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 11.15% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 6.85% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | -12.95% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -7.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | 12.24% |
| Apr 5, 2026 | 10.67% |
| Dec 28, 2025 | 14.47% |
| Sep 28, 2025 | 11.72% |
| Jun 29, 2025 | 12.60% |
| Mar 30, 2025 | 10.87% |
| Dec 29, 2024 | 16.28% |
| Sep 29, 2024 | 14.35% |
| Jun 30, 2024 | 12.39% |
| Mar 31, 2024 | 6.79% |
| Oct 1, 2023 | 10.32% |
| Jul 2, 2023 | 11.01% |
| Apr 2, 2023 | 11.28% |
| Jan 1, 2023 | 18.55% |
| Oct 2, 2022 | 15.56% |
| Jul 3, 2022 | 25.96% |
| Apr 3, 2022 | 27.20% |
| Jan 2, 2022 | 29.18% |
| Oct 3, 2021 | 22.70% |
| Jul 4, 2021 | 33.82% |